ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for EDIT

Stock NameEditas Medicine Inc
TickerEDIT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS28106W1036
LEI5299000AON4Q9NT2JE42

Show aggregate EDIT holdings

News associated with EDIT

Editas Medicine (NASDAQ:EDIT) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Editas Medicine (NASDAQ:EDIT – Free Report) in a research note published on Friday morning,Benzinga reports. The brokerage currently has a $5.00 target price on the stock. A number of other research analysts also recently issued reports on EDIT. Wall Street Zen downgraded shares of Editas Medicine […] - 2025-09-08 03:10:44
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of “Hold” from Analysts
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has received an average recommendation of “Hold” from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, two have assigned a buy recommendation and two have assigned […] - 2025-08-06 05:14:49
Editas Medicine, Inc. (NASDAQ:EDIT) Receives $5.36 Average Target Price from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been assigned a consensus rating of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation, two have given a buy recommendation and two have […] - 2025-06-20 02:20:16
Editas Medicine Reports 58% HBG1/2 Promoter Editing in Non-Human Primates Using High Efficiency tLNP Delivery Method
Editas Medicine reports 58% mean editing in HSCs after single tLNP dose, aiding sickle cell and beta thalassemia treatments. - 2025-06-12 03:10:24
Editas Medicine, Inc. (NASDAQ:EDIT) Shares Sold by Hennion & Walsh Asset Management Inc.
Hennion & Walsh Asset Management Inc. trimmed its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 3.8% during the first quarter, Holdings Channel reports. The firm owned 257,460 shares of the company’s stock after selling 10,298 shares during the quarter. Hennion & Walsh Asset Management Inc.’s holdings in Editas Medicine were […] - 2025-06-10 04:58:49
Two Sigma Advisers LP Purchases 528,000 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
Two Sigma Advisers LP raised its stake in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 46.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,657,000 shares of the company’s stock after purchasing an additional 528,000 shares during the period. […] - 2025-05-29 05:16:52
Editas Medicine, Inc. (NASDAQ:EDIT) Receives $5.36 Consensus PT from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has earned an average rating of “Hold” from the fourteen research firms that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation, two have given a buy recommendation and two have issued a strong […] - 2025-05-26 02:48:57
Stifel Financial Corp Sells 287,718 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
Stifel Financial Corp lessened its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 46.0% during the 4th quarter, HoldingsChannel reports. The fund owned 337,158 shares of the company’s stock after selling 287,718 shares during the quarter. Stifel Financial Corp’s holdings in Editas Medicine were worth $428,000 at the end of the […] - 2025-05-13 04:50:58
Invesco Ltd. Has $127,000 Stake in Editas Medicine, Inc. (NASDAQ:EDIT)
Invesco Ltd. increased its stake in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 100,164 shares of the company’s stock after acquiring an additional 8,448 shares during the quarter. Invesco Ltd.’s […] - 2025-05-06 04:28:46
Editas Medicine (NASDAQ:EDIT) Upgraded at HC Wainwright
HC Wainwright upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) to a strong-buy rating in a research report sent to investors on Monday, MarketBeat Ratings reports. The brokerage currently has $3.00 price objective on the stock. Editas Medicine Stock Up 6.5 % Shares of EDIT stock opened at $1.65 on Monday. The firm has […] - 2025-05-01 04:40:50
Cantor Fitzgerald Upgrades Editas Medicine (NASDAQ:EDIT) to Strong-Buy
Editas Medicine (NASDAQ:EDIT – Get Free Report) was upgraded by Cantor Fitzgerald from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Separately, HC Wainwright initiated coverage on Editas Medicine in a research report on Monday. They set a “buy” rating and a $3.00 price objective for the company. […] - 2025-05-01 02:38:48
XTX Topco Ltd Purchases 52,498 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
XTX Topco Ltd boosted its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 99.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 105,056 shares of the company’s stock after acquiring an additional 52,498 shares during the quarter. XTX Topco Ltd’s holdings in Editas Medicine were worth $133,000 at the end […] - 2025-04-30 05:22:59
Raymond James Financial Inc. Takes Position in Editas Medicine, Inc. (NASDAQ:EDIT)
Raymond James Financial Inc. purchased a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 238,967 shares of the company’s stock, valued at approximately $303,000. A number of other institutional […] - 2025-04-10 04:14:58
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of “Hold” from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have issued a buy recommendation on the company. […] - 2025-03-12 04:56:52
Ieq Capital LLC Makes New Investment in Editas Medicine, Inc. (NASDAQ:EDIT)
Ieq Capital LLC acquired a new stake in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 24,634 shares of the company’s stock, valued at approximately $31,000. A number of other institutional […] - 2025-03-03 06:50:57
Analysts Set Editas Medicine, Inc. (NASDAQ:EDIT) Price Target at $7.00
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have received a consensus rating of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have issued a buy recommendation on […] - 2025-02-18 04:44:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) EDIT holdings

DateNumber of EDIT Shares HeldBase Market Value of EDIT SharesLocal Market Value of EDIT SharesChange in EDIT Shares HeldChange in EDIT Base ValueCurrent Price per EDIT Share HeldPrevious Price per EDIT Share Held
2026-02-09 (Monday)71,493USD 129,402USD 129,402
2026-02-06 (Friday)71,337EDIT holding increased by 157USD 129,833EDIT holding decreased by -13239USD 129,833157USD -13,239 USD 1.82 USD 2.01
2026-02-02 (Monday)71,180USD 143,072EDIT holding increased by 1424USD 143,0720USD 1,424 USD 2.01 USD 1.99
2026-01-30 (Friday)71,180EDIT holding increased by 314USD 141,648EDIT holding decreased by -4336USD 141,648314USD -4,336 USD 1.99 USD 2.06
2026-01-29 (Thursday)70,866EDIT holding increased by 158USD 145,984EDIT holding decreased by -3210USD 145,984158USD -3,210 USD 2.06 USD 2.11
2026-01-27 (Tuesday)70,708EDIT holding increased by 159USD 149,194EDIT holding increased by 3863USD 149,194159USD 3,863 USD 2.11 USD 2.06
2026-01-26 (Monday)70,549USD 145,331EDIT holding decreased by -7055USD 145,3310USD -7,055 USD 2.06 USD 2.16
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EDIT by Blackrock for IE00BDZVHG35

Show aggregate share trades of EDIT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY157 1.820* -
2026-01-30BUY3142.0601.920 1.934USD 607 -
2026-01-29BUY1582.1102.010 2.020USD 319 -
2026-01-27BUY1592.1702.060 2.071USD 329 -
2026-01-23BUY3162.3902.150 2.174USD 687 -
2026-01-22BUY1582.4302.110 2.142USD 338 -
2026-01-15BUY3302.2202.055 2.072USD 684 -
2026-01-14BUY3322.2752.072 2.092USD 695 -
2026-01-12BUY3322.1401.990 2.005USD 666 -
2026-01-09BUY4982.2002.060 2.074USD 1,033 -
2026-01-07BUY3322.2402.130 2.141USD 711 -
2026-01-02BUY1662.0801.970 1.981USD 329 -
2025-12-30BUY1662.1302.020 2.031USD 337 -
2025-12-23SELL-1,9922.3302.120 2.141USD -4,265 -
2025-12-17SELL-8302.6102.355 2.381USD -1,976 -
2025-12-16SELL-1662.5852.425 2.441USD -405 -
2025-12-15BUY3322.5702.400 2.417USD 802 -
2025-12-11BUY3322.6902.450 2.474USD 821 -
2025-12-04BUY3,3202.4902.327 2.343USD 7,780 -
2025-12-02BUY2,4752.2302.090 2.104USD 5,207 -
2025-11-28BUY1652.4102.340 2.347USD 387 -
2025-11-26BUY4952.4102.325 2.334USD 1,155 -
2025-11-26BUY4952.4102.325 2.334USD 1,155 -
2025-11-25BUY8252.5202.350 2.367USD 1,953 -
2025-11-24BUY1652.5502.420 2.433USD 401 -
2025-11-20SELL-6602.7302.410 2.442USD -1,612 -
2025-11-19BUY1652.6552.510 2.524USD 417 -
2025-11-18BUY9902.6402.455 2.473USD 2,449 -
2025-11-17BUY3302.6702.500 2.517USD 831 -
2025-11-14BUY1652.6902.460 2.483USD 410 -
2025-11-12BUY1652.8002.650 2.665USD 440 -
2025-11-10BUY1642.7052.470 2.494USD 409 -
2025-11-06BUY1642.7902.620 2.637USD 432 -
2025-11-04BUY1642.9802.770 2.791USD 458 -
2025-10-30BUY8203.0652.940 2.953USD 2,421 -
2025-10-29BUY3283.0403.200 3.184USD 1,044 -
2025-10-22SELL-6443.5703.870 3.840USD -2,473 -
2025-10-20BUY3224.1404.275 4.262USD 1,372 -
2025-10-17BUY8033.7703.980 3.959USD 3,179 -
2025-10-15BUY1,2724.0604.170 4.159USD 5,290 -
2025-10-03BUY9873.9204.050 4.037USD 3,985 -
2025-10-02BUY1413.8903.920 3.917USD 552 -
2025-09-30BUY2823.4703.620 3.605USD 1,017 -
2025-09-26BUY2823.2403.260 3.258USD 919 -
2025-09-25BUY2823.2303.370 3.356USD 946 -
2025-09-18BUY1403.0003.073 3.066USD 429 -
2025-09-17BUY4232.7202.900 2.882USD 1,219 -
2025-07-17SELL-2782.7302.890 2.874USD -799 -
2025-07-11SELL-1,1282.8803.090 3.069USD -3,462 -
2025-07-02BUY7,7002.5602.875 2.843USD 21,895 -
2025-06-25BUY2802.1902.290 2.280USD 638 -
2025-06-11BUY2802.0302.190 2.174USD 609 -
2025-06-10BUY2802.1002.230 2.217USD 621 -
2025-06-04SELL-1401.8201.850 1.847USD -259 -
2025-04-23BUY1401.5601.690 1.677USD 235 -
2025-04-10SELL-1,1201.1101.130 1.128USD -1,263 -
2025-04-08SELL-1400.9801.070 1.061USD -149 -
2025-04-07SELL-1401.0001.050 1.045USD -146 -
2025-04-04SELL-7001.0301.150 1.138USD -797 -
2025-04-01BUY5601.1301.180 1.175USD 658 -
2025-03-31SELL-4201.1601.240 1.232USD -517 -
2025-03-14SELL-2,2401.4601.500 1.496USD -3,351 -
2025-03-07SELL-2801.7201.829 1.818USD -509 -
2025-03-04SELL-1401.7601.810 1.805USD -253 -
2025-02-25BUY2801.8601.980 1.968USD 551 -
2025-02-20SELL-1402.0602.860 2.780USD -389 -
2025-02-13BUY4201.2301.250 1.248USD 524 -
2025-02-12BUY1401.1901.220 1.217USD 170 -
2025-02-11BUY5601.1801.210 1.207USD 676 -
2024-12-30SELL-7001.2001.270 1.263USD -884 -
2024-11-18SELL-2,1002.5202.690 2.673USD -5,613 -
2024-11-08SELL-1403.1203.235 3.223USD -451 -
2024-10-21SELL-1403.7603.800 3.796USD -531 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EDIT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19456,1862,0001,110,56041.1%
2025-09-18363,4731,5751,991,61218.3%
2025-09-17231,7903,618665,41734.8%
2025-09-16392,7611,0751,278,58930.7%
2025-09-15203,749210472,70743.1%
2025-09-12137,2177,967551,43124.9%
2025-09-11169,4670685,33124.7%
2025-09-10186,715200770,42224.2%
2025-09-09149,3110681,49221.9%
2025-09-08197,4840832,26423.7%
2025-09-05350,547501,088,08532.2%
2025-09-04205,9254,399534,13638.6%
2025-09-03227,54011,202790,19228.8%
2025-09-02212,188390490,71143.2%
2025-08-29115,9041,993519,13822.3%
2025-08-28113,942950315,93736.1%
2025-08-2788,6330301,13729.4%
2025-08-2684,2150292,74928.8%
2025-08-25156,1920506,12530.9%
2025-08-22186,6600608,70730.7%
2025-08-21141,0680367,26738.4%
2025-08-20144,383102461,25231.3%
2025-08-19192,249153723,10726.6%
2025-08-18238,444100831,71428.7%
2025-08-15397,9864191,510,66326.3%
2025-08-14248,1541,119858,03328.9%
2025-08-131,234,76522,5124,431,67527.9%
2025-08-12189,4541,307539,63135.1%
2025-08-11165,15822,422733,85922.5%
2025-08-08492,64124,0021,208,61640.8%
2025-08-07124,397339397,68531.3%
2025-08-06150,3505444,36333.8%
2025-08-05217,85119716,26930.4%
2025-08-04244,0780630,32238.7%
2025-08-01324,485107715,19845.4%
2025-07-31388,4872,025930,77541.7%
2025-07-30266,68448,2231,135,80123.5%
2025-07-29426,87231,3732,052,07920.8%
2025-07-28243,9381,961934,42326.1%
2025-07-25241,8055,832673,64435.9%
2025-07-24409,5081,5081,209,43333.9%
2025-07-23446,8489,4021,259,11035.5%
2025-07-22470,7982971,393,92633.8%
2025-07-211,128,0757243,405,49633.1%
2025-07-18311,3748,7501,197,03726.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy